Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.175
Bid: 0.17
Ask: 0.18
Change: -0.01 (-5.41%)
Spread: 0.01 (5.882%)
Open: 0.185
High: 0.00
Low: 0.00
Prev. Close: 0.185
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Princess exits Taco Bell; Nuformix files patent

Fri, 12th Nov 2021 12:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Princess Private Equity Holding Ltd - Guernsey-domiciled investment holding company aiming for long-term capital growth and dividend income - Sells stake in Pacific Bells, the fifth-largest franchisee of the Taco Bell brand in the US, to Orangewood Partners. Deal values company's stake in Pacific Bells at about USD18.6 million, up slightly from carrying value of USD18.4 million at September 30.

----------

Civitas Social Housing PLC - social housing investor - Notes, alongside, Triple Point Social Housing REIT PLC, that Falcon Housing Association CIC gets notice from Regulator of Social Housing. Falcon has not received a grading as it leases fewer than 1,000 homes. "Falcon has committed to continue to engage with the RSH and in turn CSH will continue its supportive relationship with Falcon and all other counterparties with the shared objective of further enhancing standards across the sector and encouraging APs to demonstrate their independence and self-reliance," company says. Falcon represents 19.9% of Civitas's rent roll, while it is 10% of Triple Point's current portfolio.

----------

Northern Bear PLC - Newcastle Upon Tyne-based specialist building and support services company - Says it has traded well in the first half of its current financial year, ended September 30, and expects to report operating profit in the range of GBP1.4 million to GBP1.5 million, up from GBP500,000 a year prior. Operating profit for the six months to September 30 would also represent an increase on the pre-Covid comparative of GBP1.4 million. Looking ahead, the company says its forward order book remains strong and should support its trading performance in the coming months. Chair Jeff Baryshnik says: "We are pleased to announce strong expected operating results for H1 FY22, despite ongoing industry-wide challenges."

----------

Nuformix PLC - London-based pharmaceutical development firm focused on fibrosis and oncology via drug repurposing - Files a new patent application in relation to NXP004. This filing covers a new family of co-crystalline forms of an undisclosed marketed drug that is approved globally for the treatment of several cancers. This is the second patent application related to NXP004 that Nuformix has filed and it complements the previous patent application on NXP004 co-crystals.

----------

Creo Medical Group PLC - medical device company focused on surgical endoscopy - Acquires UK-based manufacturer and designer of power amplifiers and radio frequency products Aber Electronics Ltd for an unidentified sum of fixed cash consideration, plus a contingent consideration over three years. "Creo is an existing customer of Aber, using its products within the CROMA Advanced Energy Platform. This acquisition will complement Creo's research, design and manufacturing processes, provide additional specialist microwave and radio frequency capability and expertise within the business and enhance a key element of the group's supply chain," company says.

----------

Microsaic Systems PLC - Surrey, England-based mass spectrometry instruments for pharmaceutical industry - Launches new compact screening platform technology capability to its platform, as company continues to make strategic transition from equipment only sales to remote detection and analysis of human diagnostics and environmental health monitoring. New platform expected to launch in first half of 2022. Company adds: "The latest addition to Microsaic's platform is the integration of the Company's compact MS technology with Gas Chromatography and extends Microsaic's existing applications in Liquid Chromatography. This combination will provide an extensive range of analysis required by end-users for chemical detection, for use in a combined market estimated to be worth over USD1 billion."

----------

600 Group PLC - West Yorkshire, England-based manufacturer and distributor of machine tools, precision engineered components and industrial laser systems - Says its three US operations have been granted forgiveness of their second round loans under the US government paycheck protection program which in total amounts to USD2.2 million. Turning to trading, the company says it performs in line with expectations and order intake has continued to improve during the current financial year. The forward order book stands at USD23 million as at November 9, as increase when compared to the same date one year earlier, when order book was USD11 million.

----------

Powerhouse Energy Group PLC- technology company commercialising hydrogen production from waste plastic - Says its development partner Hydrogen Utopia International PLC has signed a framework agreement with Linde PLC's Engineering unit. The framework agreement provides Linde Engineering with a five year exclusivity to supply Hydrogen Utopia in its development of Powerhouse DMG technology particularly in Poland, Hungary and Greece. The Powerhouse DMG process can generate up to 2 tonnes of road-fuel hydrogen and more than 58 megawatt hours of exportable electricity per day. The project, if completed, is expected to contain ten DMG units in one geographical area.

----------

Blencowe Resources PLC - miner focused on developing the Orom-Cross graphite project in Uganda - Completes an over-subscribed capital raise for GBP2 million at 5p each through the issue of 40.0 million new shares. This includes a subscription of GBP75,000 from the directors and chief executive. These funds will be used for the further development of the mineral exploration and development company's flagship Orom-Cross graphite project in Uganda.

----------

PetroNeft Resources PLC - oil & gas exploration and production company - Says it is extending the campaign in the Tomsk Oblast, Russia, for upcoming winter with the goal of increasing production and also improving the sustained flow rate of existing wells over two producing fields in licence 61. During the first quarter of 2021, a two well fracking program was successfully completed on wells S-373 and L-115. Both were highly successful and exceeded expectations . As a result, PetroNeft signs a contract with NewTech Well Services LLC, an oilfield services company, for the provision of a larger fracking program covering an additional five wells.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2019 12:27

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Read more
10 Sep 2019 13:47

Nuformix Chief Financial Officer Kirk Siderman-Wolter Resigns Abruptly

(Alliance News) - Pharmaceutical company Nuformix PLC on Tuesday said Chief Financial Officer and Senior Independent Non-Executive Director Kirk Siderman-Wolter has resigned with immediate company

Read more
9 Sep 2019 11:25

Nuformix, Ebers Tech File Patent For Cannabinoid Cocrystals

(Alliance News) - Pharmaceutical company Nuformix PLC on Monday said it and partner Ebers Tech Inc have filed the first patent in relation to cannabinoid cocrystals.The patented cannabinoid

Read more
6 Sep 2019 12:17

Nuformix Hires Cambridge Interstitial Lung Disease Unit Lead Clinician

(Alliance News) - Nuformix PLC said on Friday it has appointed Muhunthan Thillai to its scientific advisory board with immediate effect.Thillai is the lead clinician for the Cambridge Lung

Read more
18 Jul 2019 11:16

Nuformix Annual Loss Narrows As Revenue Jumps On NXP001 Progress

(Alliance News) - Nuformix PLC on Thursday said its revenue multiplied in its most recently-ended financial year as it has secured its first licensing income from NXP001.NXP001 is one of in

Read more
30 May 2019 10:33

WINNERS & LOSERS SUMMARY: De La Rue Down As CEO Exits And Profit Falls

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - LOSERS----------National a

Read more
30 May 2019 10:14

Nuformix Shares Jump On Positive NXP001 Clinical Study Results

LONDON (Alliance News) - Shares in Nuformix PLC surged on Thursday as the company reported positive results in its clinical study of NXP001.Nuformix shares were trading 30% higher at 13.50

Read more
9 Apr 2019 11:25

Nuformix inks cannabinoid therapeutics deal with Ebers Tech

(Sharecast News) - Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commercialisation with Canadian outfit Ebers Tech.

Read more
9 Apr 2019 10:46

WINNERS & LOSERS SUMMARY: 7digital Warns Of Need For Capital Raise

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Anglo up -

Read more
22 Mar 2019 08:50

Nuformix Doses First Patient In NXP001 Anti-Nausea Drug Trial

LONDON (Alliance News) - Nuformix PLC on Friday said it has begun clinical studies for its anti-nausea drug NXP001 and dosed its first patient.Shares in Nuformix were down 4.6% at 2.10 on a

Read more
27 Feb 2019 10:48

MHRA gives go-ahead to Nuformix for human studies

(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin human pharmacokinetics studies for its lead asset, NXP001, it announced on Wednesday.

Read more
3 Dec 2018 09:53

Nuformix Reports Positive Results From NXP002 Pre-Clinical Trial

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC on Monday reported positive results from its completed NXP002 fibrosis programme pre-clinical trial for the treatment of a of

Read more
27 Nov 2018 10:04

Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner Newsummit Biopharma for the development of cancer

Read more
14 Sep 2018 10:17

Nuformix Rises As NXP001 Passes "Major" Pre-Clinical Milestone

LONDON (Alliance News) - Shares in pharmaceutical firm Nuformix PLC rose Friday it has received a GBP500,000 payment after its NXP001 product reached a pre-clinical milestone.Nuformix was a

Read more
12 Sep 2018 16:00

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 SeptemberBahamas PetroleumFlybe GroupBetter Capital PCCWorldwide 14 UK 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.